Trials / Completed
CompletedNCT03125824
Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial Protocol
Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Soliton · Industry
- Sex
- All
- Age
- 22 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To further evaluate accelerated fading resulting from additional treatment sessions of Soliton AWD as accessory to laser in tattoo reduction treatment.
Detailed description
To further evaluate accelerated fading resulting from additional treatment sessions of multi-pass Q-Switched laser with the Soliton Planar Acoustic Wave Device System (AWD) as an accessory to Q-Switched laser in tattoo reduction treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Soliton Acoustic Wave Device | Treatment of tattoos with Soliton Acoustic Wave Device as an accessory to laser |
Timeline
- Start date
- 2017-02-13
- Primary completion
- 2018-05-23
- Completion
- 2018-09-25
- First posted
- 2017-04-24
- Last updated
- 2022-02-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03125824. Inclusion in this directory is not an endorsement.